Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2021-03-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, and no meeting or voting information. The document is an official company announcement about intellectual property, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a patent grant, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories. The document length is short and it is not a report publication announcement or certification.
2021-03-21 Chinese
2021年限制性股票激励计划（草案）摘要
Remuneration Information Classification · 95% confidence The document is a detailed summary draft of a 2021 restricted stock incentive plan for a company named 迪瑞医疗科技股份有限公司. It extensively discusses the terms, conditions, legal basis, management, allocation, vesting, performance criteria, accounting treatment, and other aspects of a stock-based employee incentive plan. It references relevant laws and regulations, stock quantities, prices, and procedures for granting and vesting restricted stock to employees and management. This is a corporate governance and compensation-related document focused on equity incentives rather than financial results, audit opinions, or shareholder meeting materials. It is not an annual report, earnings release, audit report, or proxy statement. It is not a voting result announcement or a regulatory filing of a different nature. The document is a detailed plan related to remuneration and equity incentives for executives and employees. Therefore, the most appropriate classification is Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors, including stock incentive plans.
2021-03-21 Chinese
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate issued by a national regulatory authority. It includes details about the product registration, clinical use, and the company's business outlook related to these products. The document is short (1102 characters) and serves as an official notification to investors about a regulatory approval event, not a financial report or detailed management discussion. There is no financial data, earnings information, or detailed report content. It is an announcement of a regulatory milestone relevant to the company's product portfolio and market position. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-12 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 100% confidence The document is a short announcement from a company about receiving an invention patent certificate. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, no voting results, no management changes, no legal proceedings, no capital changes, and no other financial or governance report content. The document is an official announcement about intellectual property rights, which does not fit into any specific financial report category. Given its nature and length (646 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other categories.
2021-03-11 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate issued by the Chinese National Intellectual Property Administration. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, no voting results, no management changes, no capital or financing updates, and no legal proceedings. The document is an official announcement about intellectual property rights, which does not fit into any specific financial report category. Given its short length (634 characters) and nature as a formal announcement, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2021-02-26 Chinese
关于公司获得第一类医疗器械备案凭证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (755 characters) regarding the company obtaining a medical device registration certificate issued by a local market supervision bureau. It contains no financial data, no discussion of financial results, no management commentary on earnings, no voting results, no regulatory certifications, and no mention of any report being attached or published. The content is a regulatory announcement about a product certification, which does not fit into financial report categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a legal proceeding, capital update, or shareholding notification. Given the nature and length, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-02-03 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.